Method for preparing N-aryl amide compound through nitrite-mediated selenium catalysis
Intramolecular rearrangement under mild conditions through the synergistic catalysis method of nitrite and organic selenium, the problems of substrate range and environmental pollution caused by transition metal participation in the prior art are solved, and efficient and green N- Preparation of arylamide compounds, suitable for industrial production.
Patent Information
- Application Number
- CN202411082382.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-08
- Publication Date
- 2024-12-06
AI Technical Summary
The prior art lacks a simple, green and efficient method when preparing aromatic amine compounds due to the participation of transition metals, resulting in limited substrate range and environmental pollution.
The N-arylamide compound is prepared by synergistic catalysis with nitrite and organic selenium, and the intramolecular rearrangement of phenoxyamine derivatives under mild conditions, avoiding the participation of transition metals. Small molecule multivariate catalysts are used, and the catalyst is cheap and easy to use. The reaction conditions were obtained and the reaction conditions were mild.
It has achieved efficient and green aromatic amine construction, mild reaction conditions and high yields, suitable for industrial scale production, reduced environmental pollution, and developed a low-cost and fast aromatic amine construction strategy.
Smart Images

Figure CN119080631A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of organic synthesis, and in particular relates to a method for preparing N-aryl amide compounds by catalyzing selenium mediated by nitrite. Background Art
[0002] The aminophenol (ether) structural motif is widely distributed in various biologically active molecules, multifunctional materials, agricultural chemicals and monomer structures of polymers, including anticancer, anti-inflammatory, antimalarial, antibacterial and other drugs, fully demonstrating its wide application and importance in the field of medicine. For example, acetaminophen (Paractamol) with anti-inflammatory and analgesic effects, osalmide for the treatment of cholangitis, fenhexamid, a bactericide, cabozantinib for the treatment of thyroid medullary carcinoma, Benorilate, a key intermediate in the synthesis of various drugs, and Practolol, a β-adrenergic antagonist, have the following structural formulas:
[0003]
[0004] The formation of aromatic CN bonds (aromatic amines and aromatic amides) remains one of the top five reactions in synthetic organic chemistry worldwide, and is also a common method for constructing aminophenols. The methods currently used mainly include aromatization strategy, directing group functional group conversion strategy, directing group participation in CH activation strategy, and intramolecular rearrangement strategy. Among them, transition metal-catalyzed cross-coupling of amines with aromatic halides and pseudohalides to form CN bonds has become a mature technology for preparing aromatic amines in many basic and applied research fields, but the involvement of transition metals leads to problems such as limited substrate range and environmental pollution. Therefore, it is very necessary to develop a method for efficiently and greenly constructing aromatic amine compounds using simple substrates through organic small molecule catalysis. Summary of the invention
[0005] In view of the above problems, the present invention aims to provide a method for preparing N-arylamide compounds by nitrite-mediated selenium catalysis. The present invention develops a method for preparing N-arylamide compounds by catalyzing the intramolecular rearrangement of oxyamine derivatives by nitrite and organic selenium under mild conditions.
[0006] The specific technical solutions are as follows:
[0007] A method for preparing an N-aryl amide compound by nitrite-mediated selenium catalysis, using a phenoxyamine derivative shown in formula (1) as a reaction raw material, reacting in an organic solvent under the action of a catalyst and an oxidant to obtain an N-aryl amide compound shown in formula (2), the reaction formula is as follows:
[0008]
[0009] Among them, the substituent R 1 is hydrogen, alkyl, methoxy, ester, halogen or dichlorophenoxy, the substituent R 2 is alkyl, cycloalkyl, alkoxy, benzyloxy, phenyl, substituted phenyl or thiophene, and the substituent R 3 is hydrogen, substituted phenyl or alkyl, the substituent R 4 It is alkyl, substituted phenyl or phenyl, substituted phenyl mono- or poly-substituted trifluoromethyl, alkyl, halogen or methoxy.
[0010] Furthermore, the catalyst is a compound of diphenyl diselenide, nitrite and a bromine source; the nitrite is any one of sodium nitrite, potassium nitrite, calcium nitrite, copper nitrite and ammonium nitrite, or a combination of any several of them; the bromine source is any one of a hydrobromic acid solution with a mass concentration of 33%, a hydrobromic acid solution with a mass concentration of 40% (aq.), a hydrobromic acid solution with a mass concentration of 48%, pyridine hydrobromic acid and triethylamine hydrobromic acid, or a combination of any several of them.
[0011] Furthermore, the amount of diphenyl diselenide in the catalyst is 1-100 mol% of the amount of the phenoxyamine derivative shown in formula (1); the amount of nitrite in the catalyst is 1-100 mol% of the amount of the phenoxyamine derivative shown in formula (1); the amount of bromine source in the catalyst is 1-100 mol% of the amount of the phenoxyamine derivative shown in formula (1).
[0012] Furthermore, the oxidant is any one of oxygen, chlorine, hydrogen peroxide, peracetic acid, sodium hypochlorite, nitric acid, and potassium permanganate, or a combination of any two of them.
[0013] Furthermore, the organic solvent is any one of tetrahydrofuran, ethyl acetate, butyl acetate, methyl acetate, methyl formate, ethyl formate, butyl formate, 1,4-dioxane, acetonitrile, butyronitrile, valeronitrile, dichloromethane, methanol, ethanol, isopropanol, acetone, and N,N-dimethylformamide, or a combination of any two of them.
[0014] Furthermore, the concentration of the phenoxyamine derivative in the organic solvent is 0.1-1.0M.
[0015] Furthermore, the reaction temperature is 20-100°C, and the reaction time is 3-60h.
[0016] The beneficial effects of the present invention are:
[0017] 1) High reaction efficiency, high yield, simple preparation operation and mild reaction conditions;
[0018] 2) The present invention adopts nitrite and organic selenium for synergistic catalysis. Nitrite and hydrobromic acid can generate bromine in situ. Bromine will further oxidize diphenyl diselenide to phenyl selenium bromide. Under the catalytic action of phenyl selenium bromide, the phenoxyamine derivative undergoes intramolecular rearrangement to obtain the product. The nitrite and organic selenium catalytic system avoids the participation of transition metals, adopts small molecule multi-organic catalysis, and the catalyst is cheap and easy to obtain, the catalytic efficiency is high, the substrate universality is good, it is green and environmentally friendly, reduces environmental pollution, and develops an efficient, fast and low-cost aromatic amine construction strategy;
[0019] 3) The compound preparation of the present invention realizes a gram-scale reaction, is practical, has broad application prospects, and is suitable for industrial-scale production. DETAILED DESCRIPTION
[0020] The present invention is further described in detail below in conjunction with the following specific examples, and the protection content of the present invention is not limited to the following examples. Without departing from the spirit and scope of the inventive concept, the changes and advantages that can be thought of by those skilled in the art are included in the present invention, and the attached claims are the scope of protection. The process, conditions, reagents, experimental methods, etc. for implementing the present invention, except for the contents specifically mentioned below, are all common knowledge and common common sense in the art, and the present invention has no special restrictions. The data given in the following examples include specific operations and reaction conditions and products. The purity of the product is identified by nuclear magnetic resonance.
[0021] Example 1
[0022] Synthesis of Acetaminophen:
[0023]
[0024] In a dry Schlenk (15 mL) tube, 1a (30.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1a), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1a), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1a) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2a (yield 93%).
[0025] 1H NMR (400MHz, DMSO-d6) δ: 9.67 (s, 1H), 9.17 (s, 1H), 7.34 (d, J = 8.9Hz, 2H), 6.68 (d, J = 8.9Hz, 2H), 1.98 (s, 3H). 13 C NMR(100MHz,DMSO-d6)δ:167.9,153.2,131.1,120.9,115.1,23.8.MP:167.4-169.1℃.HRMS(m / z)(ESI):calcd for C8H 10 NO2[M+H] + :152.0706,found:152.0707.
[0026] Example 2
[0027] Synthesis of Acetaminophen:
[0028] In a dry Schlenk (15 mL) tube, 1a (30.2 mg, 0.2 mmol, 1.0 equiv.), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1a), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1a) were sequentially added and stirred at room temperature under oxygen for 3 hours. The reaction was monitored by TLC plate spotting, and no product 2a was detected.
[0029] Example 3
[0030] Synthesis of Acetaminophen:
[0031] In a dry Schlenk (15 mL) tube, 1a (30.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1a), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1a) were sequentially added and stirred at room temperature under oxygen for 3 hours. The reaction was monitored by TLC plate spotting, and no product 2a was detected.
[0032] Example 4
[0033] Synthesis of Acetaminophen:
[0034] In a dry Schlenk (15 mL) tube, 1a (30.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1a), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1a), 1,4-dioxane (2 mL) were sequentially added and stirred at room temperature under oxygen for 3 hours. The reaction was monitored by TLC plate spotting, and no product 2a was detected.
[0035] Example 5
[0036] Synthesis of Acetaminophen:
[0037] In a dry Schlenk (15 mL) tube, 1a (30.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1a), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1a), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol%) were sequentially added and stirred at room temperature under nitrogen for 24 hours. The reaction was monitored by TLC plate spotting, and no product 2a was detected.
[0038] Example 6
[0039] Synthesis of Acetaminophen:
[0040] In a dry Schlenk (15 mL) tube, 1a (30.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1a), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1a), 1,4-dioxane (2 mL), 55% aq. HI (1.5 μL, 0.01 mmol, 5 mol% relative to 1a) were sequentially added and stirred at room temperature under oxygen for 24 hours. The reaction was monitored by TLC plate spotting, and no product 2a was detected.
[0041] Example 7
[0042] Synthesis of Acetaminophen:
[0043]
[0044] In a dry Schlenk (15 mL) tube, 1a (30.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1a), NaNO2 (1.4 mg, 0.02 mmol, 10 mol% relative to 1a), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1a) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2a (yield 82%).
[0045] Example 8
[0046] Synthesis of Acetaminophen:
[0047]
[0048] In a dry Schlenk (15 mL) tube, 1a (30.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1a), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1a), acetonitrile (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1a) were sequentially added and stirred at room temperature under oxygen conditions for 12 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was added with anhydrous sodium sulfate to dry the filtrate, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2a (yield 51%).
[0049] Example 9
[0050] Synthesis of Acetaminophen:
[0051]
[0052] In a dry Schlenk (15 mL) tube, 1a (30.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (1.6 mg, 0.005 mmol, 2.5 mol% relative to 1a), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1a), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1a) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was added with anhydrous sodium sulfate to dry the filtrate, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2a (yield 63%).
[0053] Example 10
[0054] Synthesis of Acetaminophen:
[0055]
[0056] In a dry Schlenk (15 mL) tube, 1a (30.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1a), KNO2 (0.5 mg, 0.005 mmol, 2.5 mol% relative to 1a), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1a) were sequentially added and stirred at room temperature under oxygen conditions for 24 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2a (yield 77%).
[0057] Embodiment 11
[0058] Synthesis of Acetaminophen:
[0059]
[0060] In a dry Schlenk (15 mL) tube, 1a (30.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1a), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1a), 1,4-dioxane (2 mL), 48% aq. HBr (4.5 μL, 0.03 mmol, 15 mol% relative to 1a) were sequentially added and stirred at room temperature under oxygen conditions for 24 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was added with anhydrous sodium sulfate to dry the filtrate, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2a (yield 81%).
[0061] Example 12
[0062] Synthesis of N-(4-hydroxy-3-methylphenyl)acetamide:
[0063]
[0064] In a dry Schlenk (15 mL) tube, 1b (33.0 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1b), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1b), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1b) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was added with anhydrous sodium sulfate to dry the filtrate, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2b (yield 85%).
[0065] 1 H NMR (400MHz, DMSO-d6) δ: 9.59 (s, 1H), 9.04 (s, 1H), 7.25 (d, J = 2.8Hz, 1H), 7.17 (dd, J = 8.5, 2.8Hz, 1H), 6.68 (d, J = 8.6Hz, 1H), 2.08 (s, 3H), 1.97 (s, 3H). 13C NMR(100MHz,DMSO-d6)δ:167.6,151.3,130.9,123.7,122.2,118.2,114.4,23.8,16.3.MP:155.1-156.1℃.HRMS(m / z)(ESI):calcd for C9H 12 NO2[M+H] + :166.0863,found:166.0863.
[0066] Embodiment 13
[0067] Synthesis of N-(3-ethyl-4-hydroxyphenyl)acetamide:
[0068]
[0069] In a dry Schlenk (15 mL) tube, 1c (35.8 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1c), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1c), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1c) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2c (yield 88%).
[0070] 1 H NMR (400MHz, DMSO-d6) δ: 9.64 (s, 1H), 9.06 (s, 1H), 7.24 (d, J = 14.1Hz, 2H), 6. 71(d,J=8.5Hz,1H),2.53(t,J=7.6Hz,2H),2.00(s,3H),1.13(t,J=7.6Hz,3H). 13 C NMR(100MHz,DMSO-d6)δ:167.9,151.2,131.5,130.1,120.9,118.5,115.0,24.2,23.3,14.6.MP:151.7-153.1℃.HRMS(m / z)(ESI):calcd for C 10 H 14 NO2[M+H] + :180.1019,found:180.1018.
[0071] Embodiment 14
[0072] Synthesis of N-(3-chloro-4-hydroxyphenyl)acetamide:
[0073]
[0074] In a dry Schlenk (15 mL) tube, 1d (37.3 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1d), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1d), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1d) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2d (yield 78%).
[0075] 1 H NMR (400MHz, DMSO-d6) δ: 9.88 (s, 1H), 9.82 (s, 1H), 7.67 (d, J = 2.6Hz, 1H), 7.21 (d, J = 8.8Hz, 1H), 6.88 (d, J = 8.8Hz, 1H), 1.99 (s, 3H). 13 C NMR(100MHz,DMSO-d6)δ:168.0,148.8,131.9,120.7,119.2,119.1,116.6,23.9.MP:145.3-157.1℃.HRMS(m / z)(ESI):calcd for C8H9ClNO2[M+H] + :186.0221,found:186.0220.
[0076] Embodiment 15
[0077] Synthesis of N-(4-hydroxy-2-methylphenyl)acetamide:
[0078]
[0079] In a dry Schlenk (15 mL) tube, 1e (33.0 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1e), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1e), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1e) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was added with anhydrous sodium sulfate to dry the filtrate, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2e (yield 87%).
[0080] 1 H NMR (400MHz, DMSO-d6) δ: 9.22 (s, 1H), 9.12 (s, 1H), 7.03 (d, J = 8.4Hz, 1H), 6.62-6.49 (m, 2H), 2.09 (s, 3H), 1.99 (s, 3H). 13 C NMR(100MHz,DMSO-d6)δ:168.0,154.7,133.8,127.7,126.9,116.3,112.3,22.8,17.8.MP:160.5-161.1℃.HRMS(m / z)(ESI):calcdfor C9H 12 NO2[M+H] + :166.0863,found:166.0862.
[0081] Example 16
[0082] Synthesis of N-(2-fluoro-4-hydroxyphenyl)acetamide:
[0083]
[0084] In a dry Schlenk (15 mL) tube, 1f (33.9 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1f), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1f), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1f) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was added with anhydrous sodium sulfate to dry the filtrate, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2f (yield 85%).
[0085] 1 H NMR (400MHz, DMSO-d6) δ: 9.76 (s, 1H), 9.42 (s, 1H), 7.39 (t, J = 9.0Hz, 1H), 6.64-6.52 (m, 2H), 2.00 (s, 3H). 13 C NMR(100MHz,DMSO-d6)δ:168.4,156.5(d,J C-F =245.4Hz),155.5(d,J C-F =10.9Hz),126.6(d,J C-F =3.6Hz),117.2(d,J C-F =12.7Hz),110.9(d,J C-F =2.9Hz),102.7(d,J C-F =22.2Hz),23.1. 19 F NMR(376MHz,DMSO-d6)δ-121.93.MP:151.4-154.1℃.HRMS(m / z)(ESI):calcd for C8H9FNO2[M+H] + :170.0612,found:170.0611.
[0086] Embodiment 17
[0087] Synthesis of N-(2-bromo-4-hydroxyphenyl)acetamide:
[0088]
[0089] In a dry Schlenk (15 mL) tube, 1g (46.0 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1g), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1g), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1g) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, anhydrous sodium sulfate was added to the organic phase, the filtrate was dried, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2g (yield 83%).
[0090] 1 H NMR (400MHz, DMSO-d6) δ: 9.83 (s, 1H), 9.32 (s, 1H), 7.23 (d, J = 8.8Hz, 1H), 7.02 (d, J = 2.8Hz, 1H), 6.76 (dd, J = 8.7, 2.7Hz, 1H), 2.01 (s, 3H). 13 C NMR(100MHz,DMSO-d6)δ:168.6,156.1,129.2,127.9,119.9,118.6,115.0,23.0.MP:161.2-164.5℃.HRMS(m / z)(ESI):calcd for C8H9BrNO2[M+H] + :229.9811,found:229.9812.
[0091] Embodiment 18
[0092] Synthesis of N-(4-hydroxy-2-methoxyphenyl)acetamide:
[0093]
[0094] In a dry Schlenk (15 mL) tube, 1h (36.0 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1h), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1h), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1h) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, anhydrous sodium sulfate was added to the organic phase, the filtrate was dried, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2h (yield 73%).
[0095] 1 H NMR (400MHz, DMSO-d6) δ: 9.32 (s, 1H), 8.91 (s, 1H), 7.44 (d, J = 8.5Hz, 1H), 6.42 (d, J = 2.5Hz, 1H), 6.28 (dd, J = 8.6, 2.5Hz, 1H), 3.73 (s, 3H), 1.99 (s, 3H). 13 C NMR(100MHz,DMSO-d6)δ:168.1,155.0,151.8,124.7,118.7,106.1,99.2,55.4,23.5.MP:178.4-181.4℃.HRMS(m / z)(ESI):calcd for C9H 12 NO3[M+H] + :181.4311,found:181.4311.
[0096] Embodiment 19
[0097] Synthesis of ethyl 2-acetylamino-5-hydroxybenzoate:
[0098]
[0099] In a dry Schlenk (15 mL) tube, 1i (44.6 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1i), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1i), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1i) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=2 / 1) to obtain 2i (yield 86%).
[0100] 1 H NMR(400MHz, DMSO-d6)δ:10.14(s,1H),9.72(s,1H),7.86(d,J=8.9Hz,1H),7.26(d,J=3.0Hz ,1H),6.98(dd,J=8.9,3.0Hz,1H),4.26(q,J=7.1Hz,2H),2.04(s,3H),1.30(t,J=7.1Hz,3H). 13 C NMR(100MHz,DMSO-d6)δ:168.0,166.8,153.1,131.2,123.9,120.6,120.5,115.9,61.0,24.2,14.1.MP:157.4-160.2℃.HRMS(m / z)(ESI):calcd forC 11 H 14 NO4[M+H] + :224.0743,found:224.0743.
[0101] Embodiment 20
[0102] Synthesis of N-(4-hydroxyphenyl)propionamide:
[0103]
[0104] In a dry Schlenk (15 mL) tube, 1j (33.0 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1j), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1j), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1j) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, anhydrous sodium sulfate was added to the organic phase, the filtrate was dried, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2j (yield 92%).
[0105] 1 H NMR (400MHz, DMSO-d6) δ: 9.59 (s, 1H), 9.15 (s, 1H), 7.37 (d, J = 8.9Hz, 2H), 6.68 (d, J = 8.9Hz, 2H), 2.25 (q, J = 7.6Hz, 2H), 1.06 (t, J = 7.6Hz, 3H). 13 CNMR(100MHz,DMSO-d6)δ:171.4,153.2,131.2,120.9,115.1,29.4,10.0.MP:161.5-164.4℃.HRMS(m / z)(ESI):calcd for C9H 12 NO2[M+H] + :166.4511,found:166.4512.
[0106] Embodiment 21
[0107] Synthesis of N-(4-hydroxyphenyl)butanamide:
[0108]
[0109] In a dry Schlenk (15 mL) tube, 1k (35.8 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1k), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1k), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1k) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was added with anhydrous sodium sulfate to dry the filtrate, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2k (yield 81%).
[0110] 1 H NMR(400MHz,DMSO-d6)δ:9.60(s,1H),9.14(s,1H),7.38-7.32(m,2H),6.70-6. 63(m,2H),2.21(t,J=7.3Hz,2H),1.58(h,J=7.4Hz,2H),0.89(t,J=7.4Hz,3H). 13 C NMR(100MHz,DMSO-d6)δ:170.4,153.1,131.1,120.8,115.0,38.2,18.7,13.7.MP:135.4-137.1℃.HRMS(m / z)(ESI):calcd for C 10 H 14 NO2[M+H] + :179.2631,found:179.2632.
[0111] Embodiment 22
[0112] Synthesis of N-(4-hydroxyphenyl) dodecanamide:
[0113]
[0114] In a dry Schlenk (15 mL) tube, 1l (58.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1l), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1l), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1l) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, anhydrous sodium sulfate was added to the organic phase, the filtrate was dried, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2l (yield 83%).
[0115] 1 H NMR(400MHz,DMSO-d6)δ:9.59(s,1H),9.14(s,1H),7.35(d,J=8.8Hz,2H),6.66(d,J=8.8Hz,2H ),2.22(t,J=7.5Hz,2H),1.55(p,J=7.1Hz,2H),1.25(d,J=12.9Hz,16H),0.84(t,J=6.8Hz,3H). 13 C NMR(100MHz,DMSO-d6)δ:170.6,153.1,131.1,120.8,115.0,36.3,31.4,29.2,29.1, 29.1,28.9,28.9,28.8,25.4,22.2,14.0.MP:121.4-122.2℃.HRMS(m / z)(ESI):calcd for C 18 H 30 NO2[M+H] + :292.4182,found:292.4182.
[0116] Embodiment 23
[0117] Synthesis of N-(4-hydroxyphenyl)cyclobutanecarboxamide:
[0118]
[0119] In a dry Schlenk (15 mL) tube, 1m (38.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1m), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1m), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1m) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, anhydrous sodium sulfate was added to the organic phase, the filtrate was dried, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2m (yield 90%).
[0120] 1 H NMR(400MHz, DMSO-d6)δ:9.46(s,1H),9.15(s,1H),7.38(d,J=8.9Hz,2H),6.68(d,J=8.9Hz,2H),3 .16(p,J=8.3Hz,1H),2.28-2.16(m,2H),2.11-2.01(m,2H),1.97-1.86(m,1H),1.84-1.73(m,1H). 13 C NMR(100MHz,DMSO-d6)δ:172.2,153.2,131.1,121.0,115.1,39.6,24.7,17.9.MP:198.5-200.4℃.HRMS(m / z)(ESI):calcd for C 11 H 14 NO2[M+H] + :192.1551,found:192.1551.
[0121] Embodiment 24
[0122] Synthesis of N-(4-hydroxyphenyl)cyclopropanecarboxamide:
[0123]
[0124] In a dry Schlenk (15 mL) tube, 1n (35.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1n), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1n), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1n) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, anhydrous sodium sulfate was added to the organic phase, the filtrate was dried, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2n (yield 85%).
[0125] 1 H NMR (400MHz, DMSO-d6) δ: 9.92 (s, 1H), 9.17 (s, 1H), 7.44-7.31 (m, 2H), 6.77-6.62 (m, 2H), 1.71 (tt, J = 7.9, 4.7Hz, 1H), 0.84-0.66 (m, 4H). 13 C NMR(100MHz,DMSO-d6)δ:171.0,153.2,131.2,121.0,115.2,14.5,6.9.MP:210.4-213.2℃.HRMS(m / z)(ESI):calcdfor C 10 H 12 NO2[M+H] + :177.0822,found:177.0822.
[0126] Embodiment 25
[0127] Synthesis of tert-butyl (4-hydroxyphenyl)carbamate:
[0128]
[0129] In a dry Schlenk (15 mL) tube, 1o (41.8 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1o), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1o), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1o) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was added with anhydrous sodium sulfate to dry the filtrate, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=2 / 1) to obtain 2o (yield 84%).
[0130] 1 H NMR (400MHz, DMSO-d6) δ: 9.04 (s, 1H), 9.00 (s, 1H), 7.20 (d, J = 8.8Hz, 2H), 6.68-6.59 (m, 2H), 1.44 (s, 9H). 13 C NMR(100MHz,DMSO-d6)δ:153.0,152.5,131.0,120.0,115.0,78.5,28.2..MP:142.4-144.1℃.HRMS(m / z)(ESI):calcd for C 11 H 16 NO3[M+H] + :210.1145,found:2010.1145.
[0131] Embodiment 26
[0132] Synthesis of benzyl-N-(4-hydroxyphenyl)-carbamate:
[0133]
[0134] In a dry Schlenk (15 mL) tube, 1p (48.7 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1p), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1p), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1p) were sequentially added and stirred at room temperature under oxygen conditions for 12 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA = 2 / 1) to obtain 2p (yield 72%).
[0135] 1 H NMR (400MHz, DMSO-d6) δ: 9.45 (s, 1H), 9.13 (s, 1H), 7.46-7.36 (m, 4H), 7.36-7.30 (m, 1H), 7.23 (d, J = 8.9Hz, 2H), 6.67 (d, J = 8.9Hz, 2H), 5.11 (s, 2H). 13 C NMR(100MHz,DMSO-d6)δ:154.0,153.3,137.3,131.0,128.9,128.5,128.4,120.5,115.6,65.9.MP:122.4-125.1℃.HRMS(m / z)(ESI):calcd for C 14 H 14 NO3[M+H] + :244.0715,found:244.0715.
[0136] Embodiment 27
[0137] Synthesis of N-(4-hydroxyphenyl)benzamide:
[0138]
[0139] In a dry Schlenk (15 mL) tube, 1q (42.6 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1q), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1q), 1,4-dioxane (2 mL), 48% aq.HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1q) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was added with anhydrous sodium sulfate to dry the filtrate, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=2 / 1) to obtain 2q (yield 81%).
[0140] 1 H NMR(400MHz, DMSO-d6)δ:10.04(s,1H),9.29(s,1H),7.99-7.88(m,2H),7.59-7.47(m,5H),6.81-6.68(m,2H). 13 C NMR(100MHz,DMSO-d6)δ:165.0,153.8,135.2,131.3,130.7,128.4,127.6,122.3,115.0.MP:205.4-206.4℃.HRMS(m / z)(ESI):calcd forC 13 H 12 NO2[M+H] + :214.0944,found:244.0943.
[0141] Embodiment 28
[0142] Synthesis of N-(4-hydroxyphenyl)-4-(trifluoromethyl)benzamide:
[0143]
[0144] In a dry Schlenk (15 mL) tube, 1r (56.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1r), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1r), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1r) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=2 / 1) to obtain 2r (yield 85%).
[0145] 1 H NMR (400MHz, DMSO-d6) δ: 10.27 (s, 1H), 9.34 (s, 1H), 8.13 (d, J = 8.3Hz, 2H), 7.89 (d, J = 8.4Hz, 2H), 7.55 (d, J = 8.9Hz, 2H), 6.76 (d, J = 8.9Hz, 2H). 13 CNMR(100MHz,DMSO-d6)δ:63.8,154.0,139.0,131.2(q,J C- F=32.0Hz),130.4,128.5,125.4(q,J C-F =3.8Hz),122.7 125.4(q,J C-F =232.3Hz),115.1. 19 F NMR(376MHz,DMSO-d6)δ:-61.31.MP:188.4-189.8℃.HRMS(m / z)(ESI):calcd for C 14 H 11 F3NO2[M+H] + :282.0715,found:282.0715.
[0146] Embodiment 29
[0147] Synthesis of N-(4-hydroxyphenyl)thiophene-3-carboxamide:
[0148]
[0149] In a dry Schlenk (15 mL) tube, 1s (43.8 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1s), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1s), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1s) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, anhydrous sodium sulfate was added to the organic phase, the filtrate was dried, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2s (yield 83%).
[0150] 1 H NMR (400MHz, DMSO-d6) δ: 12.38 (s, 1H), 8.27 (s, 1H), 7.69 (dd, J = 5.1, 3.0Hz, 1H), 7.54 (d, J = 5.1Hz, 1H), 7.34 (t, J = 8.0Hz, 2H), 7.15-7.00 (m, 3H). 13 C NMR(100MHz,DMSO-d6)δ:160.9,159.7,133.8,130.2,129.6,127.6,126.4,122.5,113.0.MP:168.4-170.5℃.HRMS(m / z)(ESI):calcd for C 11 H 10 NO2S[M+H] + :220.0613,found:220.0613.
[0151] Embodiment 30
[0152] Synthesis of N-(4-hydroxyphenyl)-4-methylbenzenesulfonamide:
[0153]
[0154] In a dry Schlenk (15 mL) tube, 1t (52.6 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1t), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1t), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1t) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, anhydrous sodium sulfate was added to the organic phase, the filtrate was dried, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=2 / 1) to obtain 2t (yield 94%).
[0155] 1 H NMR (400MHz, DMSO-d6) δ: 9.68 (s, 1H), 9.32 (s, 1H), 7.54 (d, J = 8.3Hz, 2H), 7.3 0(d,J=8.3Hz,2H),6.84(d,J=8.8Hz,2H),6.60(d,J=8.8Hz,2H),2.31(s,3H). 13 C NMR(100MHz,DMSO-d6)δ:154.8,142.9,136.7,129.5,128.6,126.8,124.0,115.6,21.0.MP:178.4-180.7℃.HRMS(m / z)(ESI):calcd for C 13 H 14 NO3S[M+H] + :263.0625,found:263.0624.
[0156] Embodiment 31
[0157] Synthesis of N-(2-chloro-5-(2,4-dichlorophenoxy)-4-hydroxyphenyl)acetamide:
[0158]
[0159] In a dry Schlenk (15 mL) tube, 1u (68.8 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1u), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1u), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1u) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, anhydrous sodium sulfate was added to the organic phase, the filtrate was dried, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=2 / 1) to obtain 2u (yield 84%).
[0160] 1 H NMR (400MHz, CDCl3) δ: 7.72 (s, 1H), 7.47 (s, 1H), 7.39 (d, J = 2.5Hz, 1H), 7.13 (dd, J=8.8,2.5Hz,1H),7.01(s,1H),6.88(d,J=8.7Hz,1H),6.73(br,1H),2.13(s,3H). 13 CNMR(100MHz, CDCl3)δ:168.8,150.6,144.2,142.0,130.6,129.7,128.2,127.2, 125.7,120.3,119.0,116.8,112.6,24.5.MP:88.4-90.5℃.HRMS(m / z)(ESI):calcd forC 14 H 11 Cl3NO3[M+H] + :345.9813,found:345.9812.
[0161] Embodiment 32
[0162] Synthesis of N-(4-hydroxyphenyl)methanesulfonamide:
[0163]
[0164] In a dry Schlenk (15 mL) tube, 1v (37.4 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1v), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1v), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1v) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, anhydrous sodium sulfate was added to the organic phase, the filtrate was dried, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=2 / 1) to obtain 2v (yield 91%).
[0165] 1 H NMR (400MHz, DMSO-d6) δ: 9.39 (s, 1H), 9.19 (s, 1H), 7.04 (d, J = 8.8Hz, 2H), 6.73 (d, J = 8.9Hz, 2H), 2.84 (s, 3H). 13 C NMR(100MHz,DMSO-d6)δ:155.1,129.2,124.3,115.8,38.5.MP:130.1-133.2℃.HRMS(m / z)(ESI):calcd for C7H 10 NO3S[M+H]+:188.0412,found:184.0412.
[0166] Embodiment 33
[0167] Synthesis of N-(4-hydroxyphenyl)-2,4,6-trimethylbenzenesulfonamide:
[0168]
[0169] In a dry Schlenk (15 mL) tube, 1w (58.2 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1w), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1w), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1w) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, anhydrous sodium sulfate was added to the organic phase, the filtrate was dried, concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=2 / 1) to obtain 2w (yield 83%).
[0170] 1 H NMR (400MHz, DMSO-d6)δ:9.52(s,1H),9.33(s,1H),6.94(s,2H),6.81-6.76(m,2H),6.63-6.57(m,2H),2.44(s,6H),2.19(s,3H). 13 C NMR(100MHz,DMSO-d6)δ:155.01,141.7,138.7,133.9,131.6,128.1,124.5,115.6,22.7,20.4.MP:181.4-183.6℃.HRMS(m / z)(ESI):calcd for C 15 H 18 NO3S[M+H] + :292.4318,found:292.4318.
[0171] Embodiment 34
[0172] Synthesis of N-(4-hydroxyphenyl)benzenesulfonamide:
[0173]
[0174] In a dry Schlenk (15 mL) tube, 1x (49.8 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1x), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1x), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1x) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=2 / 1) to obtain 2x (yield 95%).
[0175] 1 H NMR(400MHz, DMSO-d6)δ:9.78(s,1H),9.37(s,1H),7.73-7.67(m,2H),7.59-7.53(m,1H),7.53-7.46(m,2H),6.93-6.85(m,2H),6.68-6.60(m,2H). 13 C NMR(100MHz,DMSO-d6)δ:155.1,139.6,132.7,129.2,128.6,126.9,124.3,115.7.MP:158.1-160.4℃.HRMS(m / z)(ESI):calcd for C 12 H 12 NO3S[M+H] + :250.0512,found:250.0511.
[0176] Embodiment 35
[0177] Synthesis of 4-bromo-N-(4-hydroxyphenyl)benzenesulfonamide:
[0178]
[0179] In a dry Schlenk (15 mL) tube, 1y (65.6 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1y), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1y), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1y) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA = 2 / 1) to obtain 2y (yield 94%).
[0180] 1 H NMR (400MHz, DMSO-d6) δ: 9.83 (s, 1H), 9.38 (s, 1H), 7.74 (d, J = 8.5Hz, 2H), 7.56 ( dd,J=8.7,2.3Hz,2H), 6.83(dd,J=8.9,3.3Hz,2H), 6.62(dd,J=8.8,2.4Hz,2H). 13 C NMR(100MHz,DMSO-d6)δ:155.2,138.7,132.2,128.8,128.1,126.5,124.4,115.7.MP:166.4-168.3℃..HRMS(m / z)(ESI):calcd for C 12 H 11 BrNO3S[M+H] + :329.9516,found:329.9516.
[0181] Embodiment 36
[0182] Synthesis of N-(4-hydroxyphenyl)-4-methoxybenzenesulfonamide:
[0183]
[0184] In a dry Schlenk (15 mL) tube, 1z (75.8 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1z), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1z), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1z) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2z (yield 95%).
[0185] 1 H NMR (400MHz, DMSO-d6) δ: 9.59 (s, 1H), 9.31 (s, 1H), 7.57 (d, J = 8.9Hz, 2H), 7.0 3(d,J=9.0Hz,2H),6.83(d,J=8.8Hz,2H),6.59(d,J=8.9Hz,2H),3.78(s,3H). 13 C NMR(100MHz,DMSO-d6)δ:162.2,154.8,131.2,128.9,128.8,124.0,115.5,114.2,55.6..MP:131.6-133.4℃.HRMS(m / z)(ESI):calcd for C 13 H 14 NO4S[M+H] + :380.0531,found:380.0532.
[0186] Embodiment 37
[0187] Synthesis of N-(4-hydroxyphenyl)-4-(trifluoromethyl)benzenesulfonamide:
[0188]
[0189] In a dry Schlenk (15 mL) tube, 1aa (63.4 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1aa), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1aa), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1aa) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2aa (yield 91%).
[0190] 1 H NMR (400MHz, DMSO-d6) δ: 10.00 (s, 1H), 9.41 (s, 1H), 7.93 (d, J = 8.5Hz, 2H), 7.85 (d, J = 8.4Hz, 2H), 6.85 (d, J = 8.8Hz, 2H), 6.63 (d, J = 8.8Hz, 2H). 13 CNMR (100MHz, DMSO-d6) δ: 155.3, 143.4, 132.4 (q, J = 32.5Hz), 127.8, 126.4 (q, J = 3.8Hz), 124.9 (q, J = 273.7Hz), 124.6, 115.8. 19 F NMR(376MHz,DMSO-d6)δ:-61.65.MP:155.4-157.1℃.HRMS(m / z)(ESI):calcd for C 13 H 11 F3NO3S[M+H] + :318.0356,found:318.0356.
[0191] Embodiment 38
[0192] Synthesis of N-(5-hydroxy-2'-methyl-[1,1'-biphenyl]-2-yl)-4-methylbenzenesulfonamide:
[0193]
[0194] In a dry Schlenk (15 mL) tube, 1ab (70.6 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1ab), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1ab), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1ab) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=2 / 1) to obtain 2ab (yield 73%).
[0195] 1 H NMR(400MHz, CDCl3)δ:7.58(d,J=8.8Hz,1H),7.38-7.32(m,2H),7.23(dd,J=7.4,1.5Hz,1H),7.17(t,J=8.2Hz,3H),7.02(td,J=7.4,1.6Hz ,1H),6.80(dd,J=8.8,2.9Hz,1H),6.49(d,J=3.0Hz,1H),6.31(dd,J=7.6,1.4Hz,1H),6.05(s,1H),5.70(br,1H),2.40(s,3H),1.79(s,3H). 13 C NMR(100MHz,DMSO-d6)δ:153.1,144.0,136.3,135.9,135.9,135.3,130.6,129.6,129.2,128.6, 127.3,126.7,126.2,123.7,116.8,115.5,21.7,19.5.MP:157.4-160.2℃.HRMS(m / z)(ESI):calcd for C 20 H 20 NO3S[M+H] + :354.1145,found:354.1145.
[0196] Embodiment 39
[0197] Synthesis of N-(1-methyl-4-oxocyclohexa-2,5-dien-1-yl)acetamide:
[0198]
[0199] In a dry Schlenk (15 mL) tube, 1ac (33.0 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1ac), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1ac), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1ac) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2ac (yield 83%).
[0200] 1 H NMR (400MHz, DMSO-d6)δ:8.33(s,1H),6.98-6.83(m,2H),6.14-5.98(m,2H),1.80(s,3H),1.35(s,3H). 13 C NMR(100MHz,DMSO-d6)δ:185.0,169.1,154.3,126.6,51.9,25.8,22.7.MP:116.1-118.4℃.HRMS(m / z)(ESI):calcd for C9H 12 NO2[M+H] + :166.0863,found:166.0862.
[0201] Embodiment 40
[0202] Synthesis of 4-methyl-N-(1-methyl-4-oxocyclohexa-2,5-dien-1-yl)benzenesulfonamide:
[0203]
[0204] In a dry Schlenk (15 mL) tube, 1ad (55.4 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1ad), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1ad), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1ad) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=2 / 1) to obtain 2ad (yield 88%).
[0205] 1 H NMR(400MHz, DMSO-d6)δ:8.37(s,1H),7.56(d,J=8.4Hz,2H),7.31(d,J=8.3H z,2H),6.67(d,J=10.1Hz,2H),5.91-5.78(m,2H),2.35(s,3H),1.33(s,3H). 13 C NMR(100MHz,DMSO-d6)δ:184.4,152.1,143.0,138.4,129.4,127.1,126.7,53.9,27.2,21.1.MP:139.6-141.4℃HRMS(m / z)(ESI):calcd for C 14 H 16 NO3S[M+H] + :278.0855,found:278.0855.
[0206] Embodiment 41
[0207] Synthesis of N-(1-methyl-4-oxocyclohexa-2,5-dien-1-yl)propionamide:
[0208]
[0209] In a dry Schlenk (15 mL) tube, 1ae (35.8 mg, 0.2 mmol, 1.0 equiv.), Ph2Se2 (3.1 mg, 0.01 mmol, 5 mol% relative to 1ae), KNO2 (0.9 mg, 0.01 mmol, 5 mol% relative to 1ae), 1,4-dioxane (2 mL), 48% aq. HBr (1.5 μL, 0.01 mmol, 5 mol% relative to 1ae) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the Schlenk tube to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2ae (yield 78%).
[0210] 1 H NMR (400MHz, DMSO-d6) δ: 8.24 (s, 1H), 6.94-6.87 (m, 2H), 6.11-6.02 (m, 2H), 2.08 (q, J = 7.6Hz, 2H), 1.35 (s, 3H), 0.94 (t, J = 7.6Hz, 3H). 13 C NMR(100MHz,DMSO-d6)δ:185.0,172.8,154.4,126.6,51.9,28.3,25.8,9.7.MP:128.4-131.8℃.HRMS(m / z)(ESI):calcd for C 10 H 14 NO2[M+H] + :180.1412,found:180.1412.
[0211] Embodiment 42
[0212] Synthesis of Pralol:
[0213]
[0214] In a dry 250 mL three-necked flask, 1a (1.12 g, 7.5 mmol, 1.0 equiv.), diphenyl diselenide (117 mg, 0.375 mmol, 5 mol% relative to 1a), KNO2 (31.8 mg, 0.375 mmol, 5 mol% relative to 1a), 1,4-dioxane (75 mL), 48% aq. HBr (46.8 μL, 0.375 mmol, 5 mol% relative to 1a) were sequentially added and stirred at room temperature under oxygen conditions for 3 hours. The reaction was monitored by TLC plate spot plate. Water was added to the 250 mL three-necked flask to quench the reaction, followed by extraction with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was dried over anhydrous sodium sulfate, the filtrate was concentrated under reduced pressure, and purified by silica gel column chromatography (PE / EA=1 / 1) to obtain 2a (1.01 g, yield 89%).
[0215] Under nitrogen conditions, 2a (1.01 g, 6.7 mmol, 1.0 equiv.), epichlorohydrin 2-1 (1.86 g, 20.1 mmol, 3.0 equiv.), and potassium carbonate (276 mg, 2.0 mmol, 0.3 equiv.) were added to a dry 50 mL three-necked flask in sequence, and the reaction temperature was raised to 120 ° C. After reacting at this temperature for 5 hours, the reaction was completed, and the reaction was cooled to room temperature. The excess solid was filtered off, and then extracted with ethyl acetate, the organic phase was collected and washed with saturated brine, the organic phase was added with anhydrous sodium sulfate, and the filtrate was dried and concentrated under reduced pressure to obtain a crude open-ring target product 2-2 for use.
[0216] Under nitrogen conditions, the crude ring-opening product 2-2 (1.02 g, 4.2 mmol, 1.0 equiv.), isopropanol (20.0 mL), and isopropylamine (2.48 g, 42.0 mmol, 10.0 equiv.) were added to a dry 50 mL three-necked flask in sequence, and the reaction temperature was raised to 100 ° C. After reflux at this temperature for 8 hours, the reaction was completed, and the reaction was cooled to room temperature, quenched with water, and then extracted with ethyl acetate. The organic phase was collected and washed with saturated brine, and the organic phase was added with anhydrous sodium sulfate to dry the filtrate, concentrated under reduced pressure, and purified by silica gel column chromatography (DCM / MeOH=10 / 1) to obtain the product pralolol 2-3 (1.06 g, yield 58%).
[0217] 1H NMR(400MHz,MeOH-d4)δ:7.42(d,J=9.1Hz,2H),6.89(d,J=9.0Hz,2H),4.06-3.99(m,1H),3.96-3.88(m,2H),2.90-2.74(m,2H),2.65(dd,J=12.0,8.5Hz,1H),2.08(s,3H),1.15-1.03(m,6H). 13 C NMR(100MHz,MeOH-d4)δ:171.3,157.0,133.2,122.9,115.6,72.1,69.8,50.8,49.9,23.6,22.6,22.4.MP:135.4-137.1℃.HRMS(m / z)(ESI):calcd forC 14 H 23 N2O3[M+H] + :267.1705,found:267.1705.
Claims
1. A method for preparing N-arylamide compounds by nitrite-mediated selenium catalysis, characterized in that: The phenoxyamine derivative shown in formula (1) is used as a reaction raw material, and in the presence of a catalyst, in an organic solvent, and in the presence of an oxidant, a reaction is performed to obtain an N-arylamide compound shown in formula (2). The reaction formula is as follows: Among them, the substituent R 1 is hydrogen, alkyl, methoxy, ester, halogen or dichlorophenoxy, the substituent R 2 is alkyl, cycloalkyl, alkoxy, benzyloxy, phenyl, substituted phenyl or thiophene, and the substituent R 3 is hydrogen, substituted phenyl or alkyl, the substituent R 4 It is alkyl, substituted phenyl or phenyl, substituted phenyl mono- or poly-substituted trifluoromethyl, alkyl, halogen or methoxy.
2. The method for preparing N-arylamide compounds by nitrite-mediated selenium catalysis as claimed in claim 1, characterized in that: The catalyst is a compound of diphenyl diselenide, nitrite and a bromine source; the nitrite is any one of sodium nitrite, potassium nitrite, calcium nitrite, copper nitrite and ammonium nitrite or a combination of any several of them; the bromine source is any one of a hydrobromic acid solution with a mass concentration of 33%, a hydrobromic acid solution with a mass concentration of 40% (aq.), a hydrobromic acid solution with a mass concentration of 48%, pyridine hydrobromic acid and triethylamine hydrobromic acid or a combination of any several of them.
3. The method for preparing N-arylamide compounds by nitrite-mediated selenium catalysis as claimed in claim 2, characterized in that: The amount of diphenyl diselenide in the catalyst is 1-100 mol% of the amount of the phenoxyamine derivative shown in formula (1); the amount of nitrite in the catalyst is 1-100 mol% of the amount of the phenoxyamine derivative shown in formula (1); the amount of bromine source in the catalyst is 1-100 mol% of the amount of the phenoxyamine derivative shown in formula (1).
4. The method for preparing N-arylamide compounds by nitrite-mediated selenium catalysis as claimed in claim 1, characterized in that: The oxidant is any one of oxygen, chlorine, hydrogen peroxide, peracetic acid, sodium hypochlorite, nitric acid, and potassium permanganate, or a combination of any two of them.
5. The method for preparing N-arylamide compounds by nitrite-mediated selenium catalysis as claimed in claim 1, characterized in that: The organic solvent is any one of tetrahydrofuran, ethyl acetate, butyl acetate, methyl acetate, methyl formate, ethyl formate, butyl formate, 1,4-dioxane, acetonitrile, butyronitrile, valeronitrile, dichloromethane, methanol, ethanol, isopropanol, acetone, and N,N-dimethylformamide, or any combination thereof.
6. The method for preparing N-arylamide compounds by nitrite-mediated selenium catalysis as claimed in claim 5, characterized in that: The concentration of the phenoxyamine derivative in the organic solvent is 0.1-1.0M.
7. The method for preparing N-arylamide compounds by nitrite-mediated selenium catalysis as claimed in claim 1, characterized in that: The reaction temperature is 20-100°C and the reaction time is 3-60h.
